Citation Impact
Citing Papers
Cost-Effectiveness of Aspirin Treatment in the Primary Prevention of Cardiovascular Disease Events in Subgroups Based on Age, Gender, and Varying Cardiovascular Risk
2008
Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection
2014
Extracellular matrix binding mixed micelles for drug delivery applications
2009 StandoutNobel
The Case for Using Albuminuria in Staging Chronic Kidney Disease
2009
Kidney stones: pathophysiology and medical management
2006 Standout
Índice de massa corporal e circunferência abdominal: associação com fatores de risco cardiovascular
2006 Standout
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Management: Part II—Drugs
2006
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2006 Standout
Recombinant Urate Oxidase (Rasburicase) in the Prophylaxis and Treatment of Tumor Lysis Syndrome
2004
Screening for Chronic Kidney Disease
2008
Tumor Lysis Syndrome and Acute Kidney Injury: Evaluation, Prevention, and Management
2010
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Regenerative medicine in rheumatic disease—progress in tissue engineering
2012
Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
2004
Rasburicase: future directions in tumor lysis management
2008
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Orlistat in hypertensive overweight/obese patients
2003
Chronic kidney disease
2011 Standout
Cost-effectiveness of a behavioral weight loss intervention for low-income women: The Weight-Wise Program
2009
A predictive model for the detection of tumor lysis syndrome during AML induction therapy
2006
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model
2007
Is There a Role for ??-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus?
2003
Manitoba and Saskatchewan administrative health care utilization databases are used differently to answer epidemiologic research questions
2007
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
A review of trends and limitations in hydrogel-rapid prototyping for tissue engineering
2012
Status and perspectives of claims data analyses in Germany—A systematic review
2016 Standout
Prevention of Venous Thromboembolism
2004 Standout
Incidence and Pathogenesis of Tumor Lysis Syndrome
2004
Chronic kidney disease: global dimension and perspectives
2013 Standout
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
2017 Standout
Screening, Monitoring, and Treatment of Albuminuria
2006
Prevention of Venous Thromboembolism
2008 Standout
Repair and tissue engineering techniques for articular cartilage
2014 Standout
Orlistat
2004
Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT)
2006
Cost-effectiveness of pharmacological anti-obesity treatments: a systematic review
2008
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA
2007
Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus
2010
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
Drug-Eluting Stents
2006
A review on 3D micro-additive manufacturing technologies
2012 Standout
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation
2009 Standout
The Tumor Lysis Syndrome
2011 Standout
Efficacy and Safety of Rasburicase (recombinant urate oxidase) for the Prevention and Treatment of Hyperuricemia During Induction Chemotherapy of Aggressive Non-Hodgkin’s Lymphoma: Results of the GRAAL1 (Groupe d’Etude des Lymphomes de l’Adulte Trial on Rasburicase Activity in Adult Lymphoma) Study
2003
Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review
2008 Standout
Myxoedema coma: Response of thyroid hormones with oral and intravenous high-dose L-thyroxine treatment
1991
Effect of clay content and silt—clay fabric on stability of artificial aggregates
1998
Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation
2004
3D printing of polymer matrix composites: A review and prospective
2016 Standout
Polymers for 3D Printing and Customized Additive Manufacturing
2017 Standout
Experimental study of 'fragipans' formation in soils. Role of both clay dispersion and wetting-drying cycles
1998
Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review
2010
Evaluation of a low, weight-based dose of rasburicase in adult patients for the treatment or prophylaxis of tumor lysis syndrome
2010
Estimating the impact of better management of glycaemic control in adults with Type 1 and Type 2 diabetes on the number of clinical complications and the associated financial benefit
2016
The rising prevalence and changing age distribution of multiple sclerosis in Manitoba
2010 Standout
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
2009 Standout
In vitro and in vivo matrix metalloproteinase expression after photodynamic therapy with a liposomal formulation of aminolevulinic acid and its methyl ester
2010
Surgery for weight loss in adults
2014 Standout
Soil structure and management: a review
2004 Standout
Assessment of Melamine and Cyanuric Acid Toxicity in Cats
2007 Standout
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
Works of Mark Lamotte being referenced
Photodynamic therapy using methyl aminolevulinate in the management of primary superficial basal cell carcinoma: clinical and health economic outcomes.
2009
The Cost Utility of Autologous Chondrocytes Implantation Using ChondroCelect® in Symptomatic Knee Cartilage Lesions in Belgium
2010
What reimbursement for coronary revascularization with drug-eluting stents?
2004
A Multi-Country Economic Evaluation of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease
2006
An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting
2004
Pan-European multicentre economic evaluation of recombinant urate oxidase (rasburicase) in prevention and treatment of hyperuricaemia and tumour lysis syndrome in haematological cancer patients
2003
Incidence, Medical Resource Utilisation and Costs of Hyperuricemia and Tumour Lysis Syndrome in Patients with Acute Leukaemia and Non-Hodgkin's Lymphoma in Four European Countries
2002
Which patients should receive aspirin for primary prevention of cardiovascular disease? An economic evaluation
2006
Validation of the IMS CORE Diabetes Model
2014
Cost-Effectiveness of Early Irbesartan Treatment Versus Control (Standard Antihypertensive Medications Excluding ACE Inhibitors, Other Angiotensin-2 Receptor Antagonists, and Dihydropyridine Calcium Channel Blockers) or Late Irbesartan Treatment in Patients With Type 2 Diabetes, Hypertension, and Renal Disease
2004
A hard sandy‐loam soil from semi‐arid Northern Cameroon: II. Geochemistry and mineralogy of the bonding agent
1997
A Health Economic Model to Assess the Long-Term Effects and Cost-Effectiveness of Orlistat in Obese Type 2 Diabetic Patients
2002
A Health Economic Evaluation of Aspirin in the Primary Prevention of Cardiovascular Disease in Japan
2007
A hard sandy‐loam soil from semi‐arid Northern Cameroon: I. Fabric of the groundmass
1997
PMS56 COST-UTILITY OF AUTOLOGOUS CHONDROCYTES IMPLANTATION USING CHONDROCELECT® IN SYMPTOMATIC KNEE CARTILAGE DAMAGE IN BELGIUM
2009
[Myxedema coma. Study of 3 cases].
1973
Cost-effectiveness analysis of clopidogrel versus aspirin in patients with atherothrombosis based on the CAPRIE trial
2003